How accurate is procalcitonin for detecting a bloodstream infection?
Procalcitonin (PCT) is a protein the body releases into the blood during serious bacterial infections. Doctors use a blood test for it as a clue that a bacterial infection may be present. The question is how well that clue actually spots a bloodstream infection (BSI), meaning bacteria growing in the blood.
The short answer: PCT is a useful but imperfect marker. In one cohort it caught roughly three out of four bloodstream infections and correctly cleared most people who did not have one 4. It is best used alongside blood cultures and clinical judgment, not as a stand-alone test.
What the research says
The most direct evidence comes from a retrospective analysis of 275 flagged blood culture bottles. In that cohort, PCT had a sensitivity of 77.41% (it correctly flagged about 77 in 100 true infections), a specificity of 91.04% (it correctly cleared about 91 in 100 people without infection), and an overall diagnostic accuracy of 82.87% 4. Mean PCT levels were somewhat higher in Gram-negative infections (37.87 ng/mL) than Gram-positive ones (35.09 ng/mL), but levels were elevated in both, so a high value does not reliably tell you which type of bacteria is involved 4.
A review of PCT use in cancer patients reached a similar overall view. It found PCT has good diagnostic value for infectious episodes, and that its accuracy looks better for major events such as bloodstream infections and sepsis than for milder infections 7. That review also noted open problems: there is no single agreed cutoff value, lab methods vary, and patient groups differ, which makes results harder to compare across settings 7. It suggested PCT works best when combined with other clinical and lab findings 7.
Other sources in this set do not measure PCT accuracy for BSI, so they cannot confirm or contradict these numbers. A prospective study of droplet digital PCR compared that test with blood culture and reported high sensitivity for BSI, but it did not evaluate PCT 5. A review of Oxford Nanopore sequencing describes its use in bloodstream infections but likewise does not test PCT 2. A meta-analysis on ceftriaxone for MSSA bloodstream infections and a cohort study on MRSA resistance patterns address treatment and epidemiology, not PCT accuracy 13.
Taken together, the evidence is thin: essentially one small retrospective cohort plus one narrative review. Both point to moderate accuracy, good at ruling in infection but with a meaningful miss rate, so a negative PCT does not rule out a bloodstream infection.
What to ask your doctor
- How would a procalcitonin result change your plan for me, given that it misses some bloodstream infections?
- Will blood cultures still be drawn even if my procalcitonin level is low?
- Does the lab here use a standard cutoff for procalcitonin, and what is it?
- Could my other conditions or treatments affect how reliable a procalcitonin result is for me?
- How will you combine procalcitonin with my symptoms and other tests when deciding on treatment?
This question is drawn from common patient questions about Infectious Disease and answered using cited medical research. We do not provide individualized advice.